In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Ozempic® (Semaglutide, Injectable pen) by Novo Nordisk has been FDA-approved since 2017 for Type 2 diabetes. Weight Method offers a separate option for Palo Alto residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month — same pricing regardless of location.
FDA-approved Ozempic prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Palo Alto is already seeing results
Ozempic in Palo Alto, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Ozempic to patients in Palo Alto from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Ozempic® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2017. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Palo Alto, CA residents starts at $199/month.
Hispanic adults in Palo Alto face disproportionately high rates of obesity and type 2 diabetes — conditions that Semaglutide therapy is studied for. Weight Method removes barriers that have historically limited access: our platform is fully bilingual, and our compounded Semaglutide program (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) starts at $199/month with no insurance needed. Everything happens virtually from your Palo Alto home.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Ozempic from $199/month.
Get Started NowFree consultation. No commitment.